Clinical Trial Update: The Hemodynamic Effects of Vasopressin in Patients With Fontan Physiology [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 trial evaluated the hemodynamic effects of vasopressin in patients with Fontan physiology and hypotension. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fontan Physiology
• Hypotension

Drugs mentioned

• VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: Stanford University | Conditions: Hypotension, Fontan Physiology | EARLY_Phase 1 | Status: COMPLETED